As part of a series of interviews with leading innovation and venture developers, Andrew Gaule, founder of the Corporate Venturing Network, talks to Graeme Martin (pictured), president of Takeda Ventures.
Gaule: Give a brief description your parent organisation and your venture.
Martin: Takeda is Japan’s largest ethical pharmaceutical business, founded in 1781. The Takeda venture function was formed in November 2001 as Takeda Research Investment, a purely strategic venture group with a $100m commitment by Takeda to invest in early-stage bioventures offering the potential to enhance and expand Takeda therapeutic discovery capabilities. As the first footprint of Takeda’s research operations outside Japan, it was also viewed as an important conduit…
